CYTARABINE EBEWE

CYTARABINE

Public price

195,00 MAD

Active substance

CYTARABINE

Laboratory

POLYMEDIC

Reimbursable

What is this medicine?

A cell cycle phase-specific antineoplastic agent and nucleoside metabolic inhibitor that acts primarily through the inhibition of DNA polymerase.

Verified summary

CYTARABINE, SOLUTION POUR PERFUSION, 50 MG / ML, FLACON DE 10ML

Common uses

Treatment of newly diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC) in adults and pediatric patients 1 year and older.

Class

Nucleoside metabolic inhibitor

Laboratory

POLYMEDIC

Availability note

Reimbursable

Hospital price

121,90 MAD

Strength

50 MG / ML

Form

SOLUTION POUR PERFUSION

Presentation

FLACON DE 10ML

Commercial status

Commercialisé AO

This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.

Price history

Reference price recorded since 2026-06-01: 195,00 MAD

Available presentations and strengths